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PAT CONCEPTS FOR THE PROCESS MONITORING AND CONTROL OF CONTINUOUS BIOMANUFACTURING
Anoushka Durve, Jeff Goby, Dr. Ying Zhu, Dr. Eike Zimmermann
Boehringer Ingelheim Biopharma, Fremont, CA
ECI ICB 2015, 2nd Conference on Integrated Continuous Biomanufacturing , Berkeley CA. Nov 1st-5th 2015.

Introduction
• Process Analytical technologies (PAT) are a key component to fully leverage the success of continuous manufacturing.
• The timely measurement of critical quality attributes and critical process parameters assures that the desired product quality is being consistently manufactured and non-conforming material being identified. PAT tools
can be utilized to meet the expectations for in-process monitoring, and allows for identification and isolation of undesired in-process materials.
• It further supports process development, as continuous and fast response of process to factor changes allows efficient experimentation and increases process understanding within the range of conditions studied during
development. Ultimately, PAT will allow Real Time Release (RTR), reduce cost, timelines and manufacturing risk.

On-line Titer Analysis of Permeate

Integrated PAT Concept for Bioreactor Monitoring
We are presenting an integrated PAT concept for the analysis of cell culture performance, titer and product quality parameters for bioreactor performance.

The PATROL®
Process Analysis
System from Waters
is an on-line UPLC
instrument, providing
access to real-time,
chromatographicquality analysis for inprocess samples.
In this study, the PATROL®
system was connected
directly to the load feedstream (HCCF permeate) of
an ÄKTA chromatography
system for continuous protein
A (ProA) purification.
Continuous sampling and
monitoring of titer has been
successfully demonstrated.
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Daily samples were drawn from bioreactors using the
Modular Automated Sampling Technology (MAST)
units by BEND Research. Bioreactor samples were
directed to a NOVA Flex unit for online metabolite
analyses. A god correlation to manual samples has
been established.

Bioreactor samples also pass through the Cell
Removal System (CRS) by BEND Research for
delivery of cell free samples to the Gilson
fraction collector for further sample preparation,
e.g. for AAA analysis or ProA purification.
Retains can be collected for additional atline/offline analysis. POC for the integral part of
the CRS and Gilson is on-going.

From here, the Waters PATROL® system
can perform on-line AAA analysis or PQ
analysis of proA purified samples, e.g.
SEC for size analysis or CEX for charge
variants.
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Example process (feed forward control)
1. Measure pH at probe 1  result
controls acid addition.
2. Measure pH at probe 2  if pH good,
flow through ≥1 hr. residence coil; if not,
divert to waste.
3. Add base.
4. Measure pH at probe 3  if pH good,
flow to AEX/CEX; if not, divert to waste.
pH probe requirements:
• 25 day process  system sterility required
 probes sterility required
• Should not need removal for maintenance,
must tolerate SIP/CIP.
• Fast response to add correct amount of
inactivation acid.

Rapid pH fall (~0.14
pH per sec)
Rapid mAb rise at
neutral pH

Rapid mAb fall at pH
3.5-5

• Accuracy (± 0.10 in 3.0-3.8 range) over
time to ensure adequate pH values.
ECI ICB 2015, 2nd Conference on Integrated Continuous Biomanufacturing, Berkley CA. Nov 1st-5th 2015.

Though potentiometric pH probes are commonly used in downstream processes, the potential drawbacks of the need for
periodic recalibration (with consequent risk of product stream contamination), susceptibility to human calibration error,
and slow response time, are of concern for sterile, continuous manufacturing systems over long periods of time. Thus,
we established POC of spectral pH measurement as an alternative approach as PAT application during low pH virus
inactivation within the desired accuracy (±0.10). We researched chromophores that are on the FDA inactive ingredient list
or GRAS list, UV absorbing, colorless, and have pKa values in desired pH range. Ascorbic acid and thiamine met the
requirements and gave a strong UV signal dependent on pH. The applied multivariate model showed ±0.07 pH accuracy
in the 3.3-4.5 range.

